The effect of HIF-1[alpha] and PKM1 expression on acquisition of chemoresistance

Background: In patients with gastric cancer, one of the greatest obstacles to effective chemotherapy is the development of chemoresistance. It has been previously reported that hypoxia-inducible factor-1 alpha (HIF-1[alpha]) is associated with acquisition of chemoresistance, and more recent studies...

Full description

Saved in:
Bibliographic Details
Published inCancer management and research Vol. 10; p. 1865
Main Authors Okazaki, Mitsuyoshi, Fushida, Sachio, Tsukada, Tomoya, Kinoshita, Jun, Oyama, Katsunobu, Miyashita, Tomoharu, Ninomiya, Itasu, Harada, Shinichi, Ohta, Tetsuo
Format Journal Article
LanguageEnglish
Published Dove Medical Press Limited 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: In patients with gastric cancer, one of the greatest obstacles to effective chemotherapy is the development of chemoresistance. It has been previously reported that hypoxia-inducible factor-1 alpha (HIF-1[alpha]) is associated with acquisition of chemoresistance, and more recent studies have also noted an association of pyruvate kinase muscle 1 (PKM1) and chemoresistance. The purpose of this study was to identify the effect of HIF-1[alpha] and PKM1 expression on the development of acquired chemoresistance using a paclitaxel (PTX)-resistant gastric cancer cell line. Materials and methods: A cancer cell line resistant to PTX was established from MKN45 cells by stepwise exposure to drug (rMKN45-PTX). The expressions of HIF-1[alpha], apoptosis, vascular endothelial growth factor (VEGF), multidrug transporters and glycolytic enzyme were examined by Western blotting, enzyme-linked immunosorbent assay and immunohistochemistry. We also assessed the tumor proliferation by subcutaneous tumor and peritoneal dissemination of mouse xenograft model. Results: The resistance index was 6.1 by determining as the ratio of the 50% growth inhibition (I[C.sub.50]) of rMKN45-PTX/I[C.sub.50] of MKN45. Expression of nuclear factor kappa B and HIF-1[alpha] was increased in rMKN45-PTX cells compared with the parent cells. Expression of Bax and caspase-3 was significantly downregulated, whereas expression of Bcl-xL, P-glycoprotein, multidrug resistance-associated protein and VEGF was increased in rMKN45-PTX. The expression level of PKM1 was upregulated in rMKN45-PTX, leading to an increase in the PKM1/PKM2 ratio. Using xenograft models, we demonstrated that mouse subcutaneous tumors derived from rMKN45-PTX were significantly larger than those derived from MKN45 cells. Conclusion: Under the stress of chemotherapeutic agent exposure, high expression of HIF-1[alpha] affects various downstream genes. Although the underlying mechanism is unknown, our data suggest that PKM1 is also a molecular target for gastric cancer treatment. Keywords: HIF-1[alpha], PKM1, chemoresistance, gastric cancer
ISSN:1179-1322
1179-1322
DOI:10.2147/CMAR.S166136